FCAM
SPPI

F&C Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

F&C Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$10.2M Sell
1,304,080
-521,013
-29% -$4.41M 0.13% 223
2013
Q4 		$16.1M Buy
1,825,093
+155,624
+9% +$1.39M 0.2% 157
2013
Q3 		$14M Buy
1,669,469
+82,587
+5% +$669K 0.18% 186
2013
Q2 		$11.8M Buy
+1,586,882
New +$12.2M 0.16% 198

Other funds holding SPPI

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

F&C Asset Management's SPPI Position: Q1 2014 in Review

F&C Asset Management reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 29% in Q1 2014, selling an estimated $4.41M and leaving 1,304,080 shares worth $10.2M. The position accounts for 0.13% of the portfolio, ranked #223.

F&C Asset Management first reported a position in SPPI in Q2 2013 and has held it in 4 quarters since. The position peaked at $16.1M in Q4 2013. 119 funds tracked by Wall St. Rank hold SPPI as of Q1 2014.

  • F&C Asset Management held 1,304,080 shares of Spectrum Pharmaceuticals Inc worth $10.2M as of Q1 2014.
  • F&C Asset Management sold 521,013 Spectrum Pharmaceuticals Inc shares in Q1 2014, an estimated $4.41M.
  • Spectrum Pharmaceuticals Inc made up 0.13% of F&C Asset Management's portfolio in Q1 2014, its #223 holding.
  • F&C Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 4 quarters since.
  • F&C Asset Management's Spectrum Pharmaceuticals Inc position peaked at $16.1M in Q4 2013.
  • 119 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.